Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cell Commun Signal ; 21(1): 30, 2023 02 03.
Artigo em Inglês | MEDLINE | ID: mdl-36737758

RESUMO

BACKGROUND: C3G is a guanine nucleotide exchange factor (GEF) that activates Rap1 to promote cell adhesion. Resting C3G is autoinhibited and the GEF activity is released by stimuli that signal through tyrosine kinases. C3G is activated by tyrosine phosphorylation and interaction with Crk adaptor proteins, whose expression is elevated in multiple human cancers. However, the molecular details of C3G activation and the interplay between phosphorylation and Crk interaction are poorly understood. METHODS: We combined biochemical, biophysical, and cell biology approaches to elucidate the mechanisms of C3G activation. Binding of Crk adaptor proteins to four proline-rich motifs (P1 to P4) in C3G was characterized in vitro using isothermal titration calorimetry and sedimentation velocity, and in Jurkat and HEK293T cells by affinity pull-down assays. The nucleotide exchange activity of C3G over Rap1 was measured using nucleotide-dissociation kinetic assays. Jurkat cells were also used to analyze C3G translocation to the plasma membrane and the C3G-dependent activation of Rap1 upon ligation of T cell receptors. RESULTS: CrkL interacts through its SH3N domain with sites P1 and P2 of inactive C3G in vitro and in Jurkat and HEK293T cells, and these sites are necessary to recruit C3G to the plasma membrane. However, direct stimulation of the GEF activity requires binding of Crk proteins to the P3 and P4 sites. P3 is occluded in resting C3G and is essential for activation, while P4 contributes secondarily towards complete stimulation. Tyrosine phosphorylation of C3G alone causes marginal activation. Instead, phosphorylation primes C3G lowering the concentration of Crk proteins required for activation and increasing the maximum activity. Unexpectedly, optimal activation also requires the interaction of CrkL-SH2 domain with phosphorylated C3G. CONCLUSION: Our study revealed that phosphorylation of C3G by Src and Crk-binding form a two-factor mechanism that ensures tight control of C3G activation. Additionally, the simultaneous SH2 and SH3N interaction of CrkL with C3G, required for the activation, reveals a novel adaptor-independent function of Crk proteins relevant to understanding their role in physiological signaling and their deregulation in diseases. Video abstract.


Assuntos
Fator 2 de Liberação do Nucleotídeo Guanina , Proteínas Nucleares , Humanos , Fatores de Troca do Nucleotídeo Guanina/metabolismo , Fator 2 de Liberação do Nucleotídeo Guanina/metabolismo , Células HEK293 , Proteínas Nucleares/metabolismo , Nucleotídeos/metabolismo , Proteínas Proto-Oncogênicas c-crk/metabolismo , Domínios de Homologia de src , Tirosina/metabolismo
2.
Sci Signal ; 13(647)2020 09 01.
Artigo em Inglês | MEDLINE | ID: mdl-32873726

RESUMO

C3G is a guanine nucleotide exchange factor (GEF) that regulates cell adhesion and migration by activating the GTPase Rap1. The GEF activity of C3G is stimulated by the adaptor proteins Crk and CrkL and by tyrosine phosphorylation. Here, we uncovered mechanisms of C3G autoinhibition and activation. Specifically, we found that two intramolecular interactions regulate the activity of C3G. First, an autoinhibitory region (AIR) within the central domain of C3G binds to and blocks the catalytic Cdc25H domain. Second, the binding of the protein's N-terminal domain to its Ras exchanger motif (REM) is required for its GEF activity. CrkL activated C3G by displacing the AIR/Cdc25HD interaction. Two missense mutations in the AIR found in non-Hodgkin's lymphomas, Y554H and M555K, disrupted the autoinhibitory mechanism. Expression of C3G-Y554H or C3G-M555K in Ba/F3 pro-B cells caused constitutive activation of Rap1 and, consequently, the integrin LFA-1. Our findings suggest that sustained Rap1 activation by deregulated C3G might promote progression of lymphomas and that designing therapeutics to target C3G might treat these malignancies.


Assuntos
Fatores de Troca do Nucleotídeo Guanina/metabolismo , Homeostase/fisiologia , Linfoma não Hodgkin/metabolismo , Proteínas rap1 de Ligação ao GTP/metabolismo , Proteínas Adaptadoras de Transdução de Sinal/metabolismo , Sequência de Aminoácidos , Animais , Biocatálise , Células COS , Linhagem Celular , Chlorocebus aethiops , Fatores de Troca do Nucleotídeo Guanina/química , Fatores de Troca do Nucleotídeo Guanina/genética , Células HEK293 , Humanos , Linfoma não Hodgkin/genética , Camundongos , Mutação , Ligação Proteica , Homologia de Sequência de Aminoácidos , Proteínas rap1 de Ligação ao GTP/genética , Domínios de Homologia de src
3.
Sci Rep ; 5: 16950, 2015 Nov 23.
Artigo em Inglês | MEDLINE | ID: mdl-26592762

RESUMO

Human carbamoyl phosphate synthetase (CPS1), a 1500-residue multidomain enzyme, catalyzes the first step of ammonia detoxification to urea requiring N-acetyl-L-glutamate (NAG) as essential activator to prevent ammonia/amino acids depletion. Here we present the crystal structures of CPS1 in the absence and in the presence of NAG, clarifying the on/off-switching of the urea cycle by NAG. By binding at the C-terminal domain of CPS1, NAG triggers long-range conformational changes affecting the two distant phosphorylation domains. These changes, concerted with the binding of nucleotides, result in a dramatic remodeling that stabilizes the catalytically competent conformation and the building of the ~35 Å-long tunnel that allows migration of the carbamate intermediate from its site of formation to the second phosphorylation site, where carbamoyl phosphate is produced. These structures allow rationalizing the effects of mutations found in patients with CPS1 deficiency (presenting hyperammonemia, mental retardation and even death), as exemplified here for some mutations.


Assuntos
Amônia/química , Carbamoil-Fosfato Sintase (Amônia)/química , Carbamoil-Fosfato/química , Glutamatos/química , Ureia/química , Motivos de Aminoácidos , Amônia/metabolismo , Animais , Baculoviridae/genética , Baculoviridae/metabolismo , Carbamoil-Fosfato Sintase (Amônia)/genética , Carbamoil-Fosfato Sintase (Amônia)/metabolismo , Doença da Deficiência da Carbamoil-Fosfato Sintase I/enzimologia , Doença da Deficiência da Carbamoil-Fosfato Sintase I/genética , Doença da Deficiência da Carbamoil-Fosfato Sintase I/patologia , Carbamoil-Fosfato/metabolismo , Clonagem Molecular , Cristalografia por Raios X , Expressão Gênica , Glutamatos/metabolismo , Humanos , Modelos Moleculares , Dados de Sequência Molecular , Mutação , Fosforilação , Estrutura Secundária de Proteína , Estrutura Terciária de Proteína , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Células Sf9 , Spodoptera , Especificidade por Substrato , Ureia/metabolismo
4.
FEBS Open Bio ; 5: 76-84, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25685666

RESUMO

RutR is a member of the large family of TetR transcriptional regulators in Escherichia coli. It was originally discovered as the regulator of the rutABCDEFG operon encoding a novel pathway for pyrimidine utilization, but its highest affinity target is the control region of the carAB operon, encoding carbamoylphosphate synthase. Unlike most other TetR-like regulators, RutR exerts both positive and negative effects on promoter activity. Furthermore, RutR exhibits a very narrow ligand binding specificity, unlike the broad effector specificity that characterizes some of the well-studied multidrug resistance regulators of the family. Here we focus on ligand binding and ligand specificity of RutR. We construct single alanine substitution mutants of amino acid residues of the ligand-binding pocket, study their effect on in vitro DNA binding in absence and presence of potential ligands, and analyse their effect on positive regulation of the carP1 promoter and negative autoregulation in vivo. Although RutR structures have been determined previously, they were deposited in the Protein Data Bank without accompanying publications. All of them have uracil bound in the effector-binding site, representing the inactive form of the regulator. We determined the crystal structure of an unliganded mutant RutR protein and provide a structural basis for the use of uracil as sole effector molecule and the exclusion of the very similar thymine from the ligand-binding pocket.

5.
PLoS One ; 7(4): e34734, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22529931

RESUMO

N-acetyl-L-glutamate kinase (NAGK) catalyzes the second, generally controlling, step of arginine biosynthesis. In yeasts, NAGK exists either alone or forming a metabolon with N-acetyl-L-glutamate synthase (NAGS), which catalyzes the first step and exists only within the metabolon. Yeast NAGK (yNAGK) has, in addition to the amino acid kinase (AAK) domain found in other NAGKs, a ~150-residue C-terminal domain of unclear significance belonging to the DUF619 domain family. We deleted this domain, proving that it stabilizes yNAGK, slows catalysis and modulates feed-back inhibition by arginine. We determined the crystal structures of both the DUF619 domain-lacking yNAGK, ligand-free as well as complexed with acetylglutamate or acetylglutamate and arginine, and of complete mature yNAGK. While all other known arginine-inhibitable NAGKs are doughnut-like hexameric trimers of dimers of AAK domains, yNAGK has as central structure a flat tetramer formed by two dimers of AAK domains. These dimers differ from canonical AAK dimers in the -110° rotation of one subunit with respect to the other. In the hexameric enzymes, an N-terminal extension, found in all arginine-inhibitable NAGKs, forms a protruding helix that interlaces the dimers. In yNAGK, however, it conforms a two-helix platform that mediates interdimeric interactions. Arginine appears to freeze an open inactive AAK domain conformation. In the complete yNAGK structure, two pairs of DUF619 domains flank the AAK domain tetramer, providing a mechanism for the DUF619 domain modulatory functions. The DUF619 domain exhibits the histone acetyltransferase fold, resembling the catalytic domain of bacterial NAGS. However, the putative acetyl CoA site is blocked, explaining the lack of NAGS activity of yNAGK. We conclude that the tetrameric architecture is an adaptation to metabolon formation and propose an organization for this metabolon, suggesting that yNAGK may be a good model also for yeast and human NAGSs.


Assuntos
Arginina/biossíntese , Fosfotransferases (Aceptor do Grupo Carboxila)/química , Fosfotransferases (Aceptor do Grupo Carboxila)/metabolismo , Saccharomyces cerevisiae/metabolismo , Aminoácido N-Acetiltransferase/química , Aminoácido N-Acetiltransferase/metabolismo , Arginina/química , Sítios de Ligação , Ativação Enzimática , Histona Acetiltransferases/química , Interações Hidrofóbicas e Hidrofílicas , Modelos Moleculares , Ligação Proteica , Dobramento de Proteína , Estrutura Terciária de Proteína
6.
Res Microbiol ; 159(3): 200-6, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18359201

RESUMO

Trehalose and glycogen are reserve carbohydrates that were shown to accumulate in mycelia of the filamentous fungus Phycomyces blakesleeanus. Both carbohydrates were mobilized under glucose starvation or in the presence of acetate. Glycogen was mobilized faster than trehalose in the presence of acetate. In all cases, glycogen and trehalose mobilization followed single exponential decay. There was a direct relationship between glycogen mobilization and the concentration of the dissociated form of external acetic acid. The half-life of glycogen mobilization increased as the concentration of the external acetate anion decreased, so the dissociated form of acetate was the stressor causing glycogen mobilization. Mobilization was not due to transfer to poor carbon sources, as the dissociated form of other weak acids (butyrate, lactate, pyruvate and propionate) also produced glycogen mobilization. Previous exposure of the mycelia to a lower acetate concentration decreased glycogen mobilization by subsequent exposure to a high acetate concentration. Glycogen mobilization by acetate may be involved in production of ATP necessary for acetate uptake as well as for maintenance of the internal pH homeostasis.


Assuntos
Ácido Acético/metabolismo , Glicogênio/metabolismo , Phycomyces/metabolismo , Trealose/metabolismo , Ácido Acético/química , Biomassa , Cinética , Micélio/metabolismo , Phycomyces/crescimento & desenvolvimento
7.
J Biochem ; 142(2): 247-55, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17875555

RESUMO

The stability of acetyl-CoA synthetases (ACS1 and ACS2) from P. blakesleeanus against temperature, urea and trypsin was studied and compared. Thermal inactivation of ACS1 was biphasic, while that of ACS2 was monophasic. The thermodynamic parameters calculated from the inactivation profiles show ACS2 to be a more thermostable enzyme than ACS1. The presence of ATP and Mg(2+) exerted a protective effect on both enzymes, and led to a marked increase in the E(a), DeltaH(not =), DeltaS(not =) and DeltaG(not =) values. ACS2 is also much more stable against denaturation with urea; the estimates of DeltaG(w) (free energy change for protein unfolding at zero denaturant concentration) were 9.4 kJ mol(-1) and 18.1 kJ mol(-1) for ACS1 and ACS2, respectively. Finally, a half-life of 44.5 min for ACS2 versus the 21 min for ACS1 indicates that ACS2 is more stable than ACS1 against digestion by trypsin. These results seem to show that ACS2 is more rigid overall than ACS1, which may be essential for preserving its catalytic activity in the stress situation in which it is expressed.


Assuntos
Acetato-CoA Ligase/química , Acetato-CoA Ligase/metabolismo , Proteínas Fúngicas/química , Proteínas Fúngicas/metabolismo , Phycomyces/enzimologia , Estabilidade Enzimática , Regulação Fúngica da Expressão Gênica , Conformação Proteica , Desnaturação Proteica , Isoformas de Proteínas/química , Isoformas de Proteínas/metabolismo , Temperatura , Termodinâmica , Fatores de Tempo , Tripsina/metabolismo , Ureia/farmacologia
8.
Res Microbiol ; 156(5-6): 663-9, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15921892

RESUMO

Two forms of acetyl-CoA synthetase (ACS1 and ACS2) have been detected in Phycomyces blakesleeanus. ACS1, encoded by the gene facA, was induced by acetate and repressed by glucose at the transcriptional level. ACS2, not encoded by the gene facA, was detected as a response to carbon starvation both in the wild type and in an facA(-) mutant. Both enzymes were purified and characterized. They can use acetate and propionate as substrates. ACS2 is a much more stable enzyme than ACS1. After 60 min incubation at 55 degrees C, ACS2 retained 50% of its activity whereas ACS1 only retained 3%. The optimum temperature was 50 degrees C for ACS2 and 30 degrees C for ACS1.


Assuntos
Coenzima A Ligases/biossíntese , Regulação Fúngica da Expressão Gênica , Phycomyces/enzimologia , Ácido Acético/metabolismo , Northern Blotting , Coenzima A Ligases/genética , Coenzima A Ligases/isolamento & purificação , Estabilidade Enzimática , Temperatura Alta , Cinética , Propionatos/metabolismo , RNA Fúngico/análise , RNA Mensageiro/análise , Especificidade por Substrato , Temperatura , Fatores de Tempo
9.
Fungal Genet Biol ; 42(5): 390-402, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15809004

RESUMO

D-Erythroascorbate and D-erythroascorbate glucoside have been identified in the Zygomycete fungus Phycomyces blakesleeanus. Ascomycete and Basidiomycete fungi also synthesise D-erythroascorbate instead of l-ascorbate, suggesting that D-erythroascorbate synthesis evolved in the common ancestor of the fungi. Both compounds accumulate in P. blakesleeanus at higher levels than observed in other fungal species. D-Erythroascorbate glucoside reduced dichlorophenolindophenol as effectively as L-ascorbate, but was more stable to autoxidation. D-Erythroascorbate glucoside predominated in spores and stationary phase mycelium. Free D-erythroascorbate accumulated during the exponential phase of mycelial growth and decreased to very low levels in the stationary phase. This suggests an association between growth and free D-erythroascorbate. P. blakesleeanus converted exogenous D-arabinose to D-erythroascorbate and its glucoside. A monomeric NAD-dependent D-arabinose dehydrogenase of 41 kDa was purified to near homogeneity. The enzyme oxidised D-arabinose, L-galactose, and L-fucose. Correspondingly, mycelium converted exogenous L-galactose and L-fucose to L-ascorbate and 6-deoxyascorbate, respectively. The antioxidant role of D-erythroascorbate and its glucoside is discussed.


Assuntos
Ácido Ascórbico/biossíntese , Ácido Ascórbico/química , Phycomyces/metabolismo , 2,6-Dicloroindofenol/química , Arabinose/metabolismo , Fucose/metabolismo , Galactose/metabolismo , Glicosilação , Peso Molecular , Micélio/química , Oxirredução , Phycomyces/enzimologia , Esporos/química , Desidrogenase do Álcool de Açúcar/química , Desidrogenase do Álcool de Açúcar/isolamento & purificação , Desidrogenase do Álcool de Açúcar/metabolismo
10.
J Bioenerg Biomembr ; 36(5): 481-92, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15534395

RESUMO

Intact Phycomyces blaskesleeanus mycelia are capable of reducing extracellular ferricyanide and this transmembrane reduction is an enzymatic process, which is enhanced by the presence of 10 mM lactate. It is modulated in response to intracellular iron levels and negatively regulated by iron and copper. It is inhibited by NEM, p CMB, iodoacetate, Zn2+, Cd2+, dicumarol, and capsaicine analog, but not by cloroquine, and activated by Ca2+, Mg2+, Na+, and K+. Ferricyanide reduction was concomitant with proton release into the extracellular medium, both processes being greatly promoted by vitamin K3 following hyperbolic saturation kinetics with regard to ferricyanide concentration. No stoichiometric proton release was observed with regard to ferricyanide reduction in the absence or the presence of vitamin K3. Proton release coupled with ferricyanide reductase activity does not appear to be due to H+-ATPase. The relevance of these findings to the relationship between the two processes is discussed.


Assuntos
Membrana Celular/metabolismo , Ferricianetos/farmacocinética , Ferro/metabolismo , Phycomyces/metabolismo , Vitamina K 3/metabolismo , Taxa de Depuração Metabólica , NADH NADPH Oxirredutases/metabolismo , Oxirredução
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...